Clinical Trials Directory

Trials / Conditions / Larynx

Larynx

23 registered clinical trials studyying Larynx3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPrevalence of EILO Among Children With Asthma
NCT06480084
Medisch Spectrum TwenteN/A
RecruitingVoice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty
NCT06439290
University GhentN/A
SuspendedLaryngeal Allograft Transplantation
NCT03269396
Mayo ClinicN/A
CompletedUltrasound Assessment of the Larynx and Trachea in the Neonatal Period
NCT05636410
Princess Anna Mazowiecka Hospital, Warsaw, Poland
UnknownTeach Intubation by Novices in Anaesthesiology
NCT05145556
Johannes Gutenberg University MainzN/A
CompletedBilateral Elective Neck Dissection in Salvage Total Laryngectomy
NCT05746780
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active Not RecruitingDurvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
NCT03529422
UNC Lineberger Comprehensive Cancer CenterPhase 2
Active Not RecruitingNivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
NCT03854032
Thomas Jefferson UniversityPhase 2
WithdrawnCLE During Exercise Testing in Asthma
NCT04168671
Helsinki University Central HospitalN/A
UnknownWindow of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to
NCT03737968
Yonsei UniversityPhase 2
CompletedVocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
NCT05565430
Monash Medical Centre
RecruitingAccuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea
NCT03109171
Fundación Neumologica ColombianaN/A
CompletedWindow of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head an
NCT03238365
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEARLY_Phase 1
WithdrawnThe Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome
NCT02065128
Unity Health Toronto
CompletedNivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
NCT03162731
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEARLY_Phase 1
TerminatedMetformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma
NCT03076281
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
CompletedMetformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
NCT03109873
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEARLY_Phase 1
CompletedRelationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-di
NCT03030781
King Fahad Medical City
CompletedInnervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal N
NCT02761239
Sisli Hamidiye Etfal Training and Research HospitalN/A
CompletedA Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
NCT02126969
Susanne ArnoldPhase 2
CompletedExamining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube
NCT01263873
University Hospitals Cleveland Medical CenterN/A
CompletedStudy for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy
NCT01649973
National Medical Center, Seoul
CompletedEx Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
NCT01321892
Icahn School of Medicine at Mount Sinai